methyl 5,5-dimethyl-13-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6,12-trioxatricyclo[7.4.0.0˛,?]tridec-10-ene-10-carboxylate



Compound IDCDAMM00190
Common namemethyl 5,5-dimethyl-13-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6,12-trioxatricyclo[7.4.0.0˛,?]tridec-10-ene-10-carboxylate
IUPAC namemethyl 5,5-dimethyl-13-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,6,12-trioxatricyclo[7.4.0.02,7]tridec-10-ene-10-carboxylate
Molecular formulaC20H30O11

Experimental data

Retention time31.64
Adduct[M+NH4]+
Actual mz464.212
Theoretical mz464.213
Error0.28
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.8344

Identifiers and class information

Inchi keyYAIGDKVCMQAHRK-HPMMZJQZNA-N
SmilesCC1(OCC2C(O1)CC3C2C(OC=C3C(=O)OC)OC4C(C(C(C(O4)CO)O)O)O)C
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)446.45
Computed dipole moment(dipole)6.605
Total solvent accessible surface area (SASA)677.114
Hydrophobic component of SASA (FOSA)444.023
Hydrophilic component of SASA (FISA)196.147
Pie component of the SASA (PISA)36.944
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1267.38
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)15.4
Free energy of solvation of dipole (dip^2/V)0.0344274
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0454871
Globularity descriptor (glob)0.836449
Predicted polarizability in cubic angstroms (QPpolrz)39.782
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.532
Predicted octanol/gas partition coefficient (QPlogPoct)27.656
Predicted water/gas partition coefficient (QPlogPw)22.197
Predicted octanol/water partition coefficient (QPlogPo/w)-0.432
Predicted aqueous solubility (QPlogS)-2.623
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.576
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.355
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)136.721
Predicted brain/blood partition coefficient (QPlogBB)-1.788
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)57.583
Predicted skin permeability, log Kp (QPlogKp)-4.236
PM3 calculated ionization potential (IP(ev))9.588
PM3 calculated electron affinity (EA(eV))-0.109
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-0.928
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)49.683
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)157.989
Number of nitrogen and oxygen atoms (#NandO)11
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
Q9BZP6CHIAAcidic mammalian chitinase (by homology)T51597SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA
P17931LGALS3Galectin-3T72038SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
P20916MAGMyelin-associated glycoprotein (by homology)T95286SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T95286DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P20916MAG

Copyright © 2025